Top of this page
Skip navigation, go straight to the content

We are connecting with world class partners to build on our strengths and to collaborate with those who have strengths in complementary fields.

UK Partnerships

Establishing successful partnerships is fundamental to the success of UCB as the complexities of severe diseases are beyond the expertise and resource of a single organisation. Through partnerships, UCB can optimise its product pipeline in its core therapeutic areas.

The Centre for Collaborative Research (CfCR) is based in Slough, and supports collaboration with academics and biotech companies to investigate new targets for possible development.
The CfCR aims to develop new collaborative projects with academic and biotechnology partners by providing access to UCB's world-class antibody generation and engineering capabilities. The CfCR is currently seeking project proposals in the area of immunology. Key areas of interest include, but are not limited to:

  • rheumatology, for example rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE)
  • severe asthma and chronic obstructive pulmonary disease (COPD)
  • osteoarthritis and osteoporosis
  • fibrotic disease and scleroderma
  • immune tolerance.

Collaboration

Collaborations have been established with scores of academic institutions and leading drug discovery organisations in the UK to improve discovery, research and early clinical stage development. UCB also supports research conducted by other UK organisations.

UCB purchasing

Global Purchasing supports UCB’s overall supply requirements through strategic sourcing, integrated business processes and data management.